Compare Novo Nordisk A/S (NVO) vs Payoneer Global Inc (PAYO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Payoneer Global Inc — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Payoneer Global Inc trades at $7.13 (market cap $2.41B). The key difference: Novo Nordisk A/S is far larger — about 91.5× Payoneer Global Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Payoneer Global Inc pays none. Which is the better fit depends on your goals.
| NVO | PAYO | |
|---|---|---|
Market Cap | $220.53B | $2.41B |
Sector | Health | Technology |
52-Week High | $71.70 | $7.42 |
52-Week Low | $35.29 | $4.27 |
Enterprise Value | $239.49B | $2.15B |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →
